Cargando…

Patient Participation and the Use of Ehealth Tools for Pharmacoviligance

In recent years, pharmacovigilance has undergone some major changes. First, the patient’s active role in identifying and describing adverse drug reactions (ADRs) has gained recognition. Second, pharmacovigilance has increasingly incorporated information and communications technology (ICT). Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Berrewaerts, Joëlle, Delbecque, Laure, Orban, Pierre, Desseilles, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827142/
https://www.ncbi.nlm.nih.gov/pubmed/27148052
http://dx.doi.org/10.3389/fphar.2016.00090
_version_ 1782426427333804032
author Berrewaerts, Joëlle
Delbecque, Laure
Orban, Pierre
Desseilles, Martin
author_facet Berrewaerts, Joëlle
Delbecque, Laure
Orban, Pierre
Desseilles, Martin
author_sort Berrewaerts, Joëlle
collection PubMed
description In recent years, pharmacovigilance has undergone some major changes. First, the patient’s active role in identifying and describing adverse drug reactions (ADRs) has gained recognition. Second, pharmacovigilance has increasingly incorporated information and communications technology (ICT). Patients can now upload their own reports of ADRs online. Data on intensive medication monitoring are now collected via the Internet and smartphones. Worldwide collection of AEs using smart phones might become the leading technique in Low and Middle Income Countries where broad mobile phone service can be managed cheaper than Internet communication. At the same time, researchers are exploring the potential for data sharing via online forums and Internet search engines. In particular we synthetize the Pros and cons of the various methods for gathering pharmacovigilance data (i.e., Web-based spontaneous reporting of adverse drug reactions; Intensive drug monitoring studies; Analysis of online forum postings; Use of mobile phone systems to monitor drug effects). This article describes these advances and highlights their respective contributions.
format Online
Article
Text
id pubmed-4827142
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48271422016-05-04 Patient Participation and the Use of Ehealth Tools for Pharmacoviligance Berrewaerts, Joëlle Delbecque, Laure Orban, Pierre Desseilles, Martin Front Pharmacol Pharmacology In recent years, pharmacovigilance has undergone some major changes. First, the patient’s active role in identifying and describing adverse drug reactions (ADRs) has gained recognition. Second, pharmacovigilance has increasingly incorporated information and communications technology (ICT). Patients can now upload their own reports of ADRs online. Data on intensive medication monitoring are now collected via the Internet and smartphones. Worldwide collection of AEs using smart phones might become the leading technique in Low and Middle Income Countries where broad mobile phone service can be managed cheaper than Internet communication. At the same time, researchers are exploring the potential for data sharing via online forums and Internet search engines. In particular we synthetize the Pros and cons of the various methods for gathering pharmacovigilance data (i.e., Web-based spontaneous reporting of adverse drug reactions; Intensive drug monitoring studies; Analysis of online forum postings; Use of mobile phone systems to monitor drug effects). This article describes these advances and highlights their respective contributions. Frontiers Media S.A. 2016-04-11 /pmc/articles/PMC4827142/ /pubmed/27148052 http://dx.doi.org/10.3389/fphar.2016.00090 Text en Copyright © 2016 Berrewaerts, Delbecque, Orban and Desseilles. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Berrewaerts, Joëlle
Delbecque, Laure
Orban, Pierre
Desseilles, Martin
Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
title Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
title_full Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
title_fullStr Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
title_full_unstemmed Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
title_short Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
title_sort patient participation and the use of ehealth tools for pharmacoviligance
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827142/
https://www.ncbi.nlm.nih.gov/pubmed/27148052
http://dx.doi.org/10.3389/fphar.2016.00090
work_keys_str_mv AT berrewaertsjoelle patientparticipationandtheuseofehealthtoolsforpharmacoviligance
AT delbecquelaure patientparticipationandtheuseofehealthtoolsforpharmacoviligance
AT orbanpierre patientparticipationandtheuseofehealthtoolsforpharmacoviligance
AT desseillesmartin patientparticipationandtheuseofehealthtoolsforpharmacoviligance